Abdel-Kahaar E, Keller F (2023) Clinical pharmacokinetics and pharmacodynamics of voclosporin. Clin Pharmacokinet 62(5):693–703. https://doi.org/10.1007/s40262-023-01246-2
Article CAS PubMed PubMed Central Google Scholar
Arumugam TV, Granger DN, Mattson MP (2005) Stroke and T-cells. Neuromol Med 7(3):229–242. https://doi.org/10.1385/NMM:7:3:229
Chaturvedi M, Kaczmarek L (2014) Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol 49(1):563–573. https://doi.org/10.1007/s12035-013-8538-z
Article CAS PubMed Google Scholar
Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, Hu B (2019) Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis 10(7):487. https://doi.org/10.1038/s41419-019-1716-9
Article CAS PubMed PubMed Central Google Scholar
Davis S, Donnan G (2009) The ECASS III results and the tPA paradox. Int J Stroke 4(1):17–18. https://doi.org/10.1111/j.1747-4949.2009.00248.x
He Q, Ma Y, Fang C, Deng Z, Wang F, Qu Y, Guo ZN (2023) Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC. Pharmacol Res 187:106641. https://doi.org/10.1016/j.phrs.2022.106641
Article CAS PubMed Google Scholar
Heo YA (2021) Voclosporin: first approval. Drugs 81(5):605–610. https://doi.org/10.1007/s40265-021-01488-z
Article CAS PubMed PubMed Central Google Scholar
Hernandez IH, Villa-Gonzalez M, Martin G, Soto M, Perez-Alvarez MJ (2021) Glial cells as therapeutic approaches in brain ischemia–reperfusion injury. Cells. https://doi.org/10.3390/cells10071639
Article PubMed PubMed Central Google Scholar
Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49(7):1215–1228. https://doi.org/10.1093/rheumatology/keq031
Article CAS PubMed Google Scholar
Kang R, Gamdzyk M, Lenahan C, Tang J, Tan S, Zhang JH (2020) The dual role of microglia in blood–brain barrier dysfunction after stroke. Curr Neuropharmacol 18(12):1237–1249. https://doi.org/10.2174/1570159X18666200529150907
Article CAS PubMed PubMed Central Google Scholar
Kawa H, Ahmed Z, Majid A, Chen R (2025) Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: go broad or go narrow? Neuropharmacology 262:110192. https://doi.org/10.1016/j.neuropharm.2024.110192
Article CAS PubMed Google Scholar
Khaja AM, Grotta JC (2007) Established treatments for acute ischaemic stroke. Lancet 369(9558):319–330. https://doi.org/10.1016/S0140-6736(07)60154-8
Article CAS PubMed Google Scholar
Khassafi N, Azami Tameh A, Mirzaei H, Rafat A, Barati S, Khassafi N, Vahidinia Z (2024) Crosstalk between Nrf2 signaling pathway and inflammation in ischemic stroke: mechanisms of action and therapeutic implications. Exp Neurol 373:114655. https://doi.org/10.1016/j.expneurol.2023.114655
Article CAS PubMed Google Scholar
Lebrun F, Levard D, Lemarchand E, Yetim M, Furon J, Potzeha F, Vivien D (2024) Improving stroke outcomes in hyperglycemic mice by modulating tPA/NMDAR signaling to reduce inflammation and hemorrhages. Blood Adv 8(5):1330–1344. https://doi.org/10.1182/bloodadvances.2023011744
Article CAS PubMed PubMed Central Google Scholar
Lenglet S, Montecucco F, Denes A, Coutts G, Pinteaux E, Mach F, Copin JC (2014) Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice. J Cereb Blood Flow Metab 34(5):802–812. https://doi.org/10.1038/jcbfm.2014.9
Article CAS PubMed PubMed Central Google Scholar
Li PA, Kristian T, He QP, Siesjo BK (2000) Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia. Exp Neurol 165(1):153–163. https://doi.org/10.1006/exnr.2000.7459
Article CAS PubMed Google Scholar
Li Y, Zhong W, Jiang Z, Tang X (2019) New progress in the approaches for blood-brain barrier protection in acute ischemic stroke. Brain Res Bull 144:46–57. https://doi.org/10.1016/j.brainresbull.2018.11.006
Article CAS PubMed Google Scholar
Li Y, Liu B, Zhao T, Quan X, Han Y, Cheng Y, Zhao Y (2023) Comparative study of extracellular vesicles derived from mesenchymal stem cells and brain endothelial cells attenuating blood-brain barrier permeability via regulating Caveolin-1-dependent ZO-1 and Claudin-5 endocytosis in acute ischemic stroke. J Nanobiotechnol 21(1):70. https://doi.org/10.1186/s12951-023-01828-z
Li J, Wang Z, Li J, Zhao H, Ma Q (2024) HMGB1: a new target for ischemic stroke and hemorrhagic transformation. Transl Stroke Res. https://doi.org/10.1007/s12975-024-01258-5
Article PubMed PubMed Central Google Scholar
Liu C, Xie J, Sun S, Li H, Li T, Jiang C, Wang W (2022a) Hemorrhagic transformation after tissue plasminogen activator treatment in acute ischemic stroke. Cell Mol Neurobiol 42(3):621–646. https://doi.org/10.1007/s10571-020-00985-1
Article CAS PubMed Google Scholar
Liu D, Ji Q, Cheng Y, Liu M, Zhang B, Mei Q, Zhou S (2022b) Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice. J Nanobiotechnol 20(1):256. https://doi.org/10.1186/s12951-022-01474-x
Long J, Sun Y, Liu S, Yang S, Chen C, Zhang Z, Chen N (2023) Targeting pyroptosis as a preventive and therapeutic approach for stroke. Cell Death Discov 9(1):155. https://doi.org/10.1038/s41420-023-01440-y
Article CAS PubMed PubMed Central Google Scholar
Lulic D, Burns J, Bae EC, van Loveren H, Borlongan CV (2011) A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury. Neurosurgery 68(5):1172–1185. https://doi.org/10.1227/NEU.0b013e31820c6cdc. (discussion 1185-1176)
Mendelson SJ, Prabhakaran S (2021) Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review. JAMA 325(11):1088–1098. https://doi.org/10.1001/jama.2020.26867
Article CAS PubMed Google Scholar
Montellano FA, Ungethum K, Ramiro L, Nacu A, Hellwig S, Fluri F, Heuschmann PU (2021) Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review. Stroke 52(2):543–551. https://doi.org/10.1161/STROKEAHA.120.029232
Article CAS PubMed Google Scholar
Park YJ, Yoo SA, Kim M, Kim WU (2020) The role of calcium-calcineurin-NFAT signaling pathway in health and autoimmune diseases. Front Immunol 11:195. https://doi.org/10.3389/fimmu.2020.00195
Article CAS PubMed PubMed Central Google Scholar
Planas AM (2024) Role of microglia in stroke. Glia 72(6):1016–1053. https://doi.org/10.1002/glia.24501
Article CAS PubMed Google Scholar
Rovin BH, Teng YKO, Ginzler EM, Arriens C, Caster DJ, Romero-Diaz J, Huizinga RB (2021) Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 397(10289):2070–2080.
Comments (0)